Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction Ahmed S. ElserafyAshraf RedaEmad R. Issak Current Opinion Open access 15 November 2021 Pages: 1027 - 1036
Efficacy of Interferon-β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis Subodh KumarManoj Kumar SaurabhVikas Maharshi Systematic Review 23 October 2021 Pages: 1037 - 1046
The Intraoperative Median Effective Dose of Oxytocin for Preventing Uterine Atony in Parturients with a Prior History of Caesarean Delivery Chang Na WeiDan DrzymalskiXin Zhong Chen Original Research Article 16 October 2021 Pages: 1047 - 1053
Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study Narcís CardonerAntoni Sicras-MainarBeatriz Armada Original Research Article 06 November 2021 Pages: 1055 - 1066
Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS Seth C. HopkinsAjay OgiralaKenneth S. Koblan Original Research Article Open access 09 November 2021 Pages: 1067 - 1073
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan Itaru HiraishiRie UenoShinichiroh Maekawa Original Research Article Open access 16 November 2021 Pages: 1075 - 1086
An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer Pain Eiso HiyamaShigeki YamaguchiTakaaki Terahara Original Research Article 16 November 2021 Pages: 1087 - 1098
Subcutaneous Infliximab, CT-P13 SC: A Profile of Its Use in the EU Matt Shirley Adis Drug Q&A 02 November 2021 Pages: 1099 - 1107
